Research Article
High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes
Table 3
Serum concentration of PFOA and PFOS (ng/mL) in study population.
| | | Mean ± SD | Median | GM | value | Min | Max | 25th | 75th | 95% CI |
| PFOA (ng/mL) | | | | | 0.160 | | | | | | T1DM | 25 | 0.53 ± 0.10 | 0.49 | 0.52 | | 0.46 | 0.83 | 0.48 | 0.55 | 0.07–0.13 | Control | 19 | 0.50 ± 0.06 | 0.48 | 0.50 | | 0.45 | 0.67 | 0.46 | 0.50 | 0.05–0.10 | PFOS (ng/mL) | | | | | <0.001 | | | | | | T1DM | 25 | 1.53 ± 1.51 | 0.95 | 1.09 | | 0.48 | 6.68 | 0.50 | 1.84 | 1.18–2.10 | Control | 19 | 0.56 ± 0.16 | 0.49 | 0.54 | | 0.47 | 0.93 | 0.48 | 0.50 | 0.12–0.23 |
|
|
GM: geometric mean; PFOA: perfluorooctanoic acid; PFOS: perfluorooctane sulfonate; SD: standard deviation; T1DM: type 1 diabetes.
|